Andrew Alexis, MD, MPH
Articles
August 21st 2025
Bridging the Gaps: Health Care Professional Knowledge Gaps in AD Pathophysiology
Ryan Haumschild, PharmD, MS, MBA, CPEL Andrew Alexis, MD, MPH April W. Armstrong, MD, MPH Andrew M. Mastro, MS, PA-C Mark Makhinson, PharmD
Panelists discuss how health care professionals face educational gaps in understanding atopic dermatitis (AD) immunopathogenesis, with advanced practice providers (APPS) particularly needing additional training outside standard curricula to master biologic therapy selection.
August 21st 2025
Understanding Atopic Dermatitis as an Immune-Mediated Disease
Ryan Haumschild, PharmD, MS, MBA, CPEL Andrew Alexis, MD, MPH April W. Armstrong, MD, MPH Andrew M. Mastro, MS, PA-C Mark Makhinson, PharmD
Panelists discuss how atopic dermatitis involves complex inflammatory and neuronal pathways, with IL-4, IL-13, and IL-31 cytokines driving Th2-mediated inflammation that varies across different racial populations.
Latest Updated Articles
Published: June 6th 2025 | Updated: August 18th 2025
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
Published: June 27th 2025 | Updated: July 1st 2025
Report Reveals Mounting Burdens of Drug Shortages on US Health System
Published: February 20th 2025 | Updated: February 21st 2025
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
Published: January 16th 2025 | Updated: January 29th 2025
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
